Binding site
Translocator protein (TSPO)
Translocator protein (peripheral benzodiazepine receptor, PBR)
- GeneTSPO
- FamilyTranslocator protein (TSPO)
The peripheral-type benzodiazepine receptor was identified in 1977 in a search for binding sites for diazepam in peripheral tissues. It is a widely distributed transmembrane protein, located mainly in the outer mitochondrial membrane, that binds drug ligands with high affinity and binds cholesterol. It has been linked to cholesterol transport and the synthesis of steroid hormones, porphyrin transport and heme synthesis, apoptosis, cell proliferation, anion transport, the regulation of mitochondrial functions and immunomodulation. In 2006 the name translocator protein (18 kDa) was proposed for it.1
Sources (1)
- Papadopoulos et al. 2006Papadopoulos V, Baraldi M, Guilarte TR, et al. (2006) Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function Trends Pharmacol Sci
Binding affinity (Kᵢ)
1 substance, 1 displayed value. Strongest first within each organism. The bar is pKᵢ on a log scale. Open a row to see the assay and every report behind the value.
Unspecified
1 measurement
AL-LAD1000 nMJain et al. 2025
- Assay
- radioligand competition binding, peripheral benzodiazepine receptor / TSPO (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
Values are published numbers in nM per organism. Different assays, species and receptor preparations are not directly interchangeable, and a value does not establish clinical potency or safety.